ALR Technologies SG (ALRTF) Liabilities and Shareholders Equity (2021 - 2025)
ALR Technologies SG (ALRTF) posted Liabilities and Shareholders Equity of $47374.0 for Q4 2025, up 52.81% on a QoQ basis from $31002.0 in Q2 2025, and down 40.39% year-over-year from $79472.0 in Q4 2024.
ALR Technologies SG (ALRTF) Liabilities and Shareholders Equity (2021 - 2025) Analysis & Trends
ALR Technologies SG's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $47374.0 for Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 40.39% year-over-year to $47374.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $203688.0 (down 78.81% YoY) and the FY2025 annual result came in at $47374.0, down 40.39% from the prior year.
- Liabilities and Shareholders Equity was $47374.0 for Q4 2025 at ALR Technologies SG, up from $31002.0 in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $680562.0 in Q2 2023 and bottomed at $31002.0 in Q2 2025.
- A 5-year average of $201244.2 and a median of $117335.0 in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 95.27% — and 2024, when it sank 93.26%.
- ALR Technologies SG's Liabilities and Shareholders Equity stood at $193217.0 in 2021, then jumped by 95.27% to $377289.0 in 2022, then tumbled by 58.86% to $155198.0 in 2023, then plunged by 48.79% to $79472.0 in 2024, then tumbled by 40.39% to $47374.0 in 2025.
- Business Quant data shows ALRTF's Liabilities and Shareholders Equity at $47374.0 in Q4 2025, $31002.0 in Q2 2025, and $79472.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | ALR Technologies SG | 61.20 Mn | 61.18 Mn | - | 47,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47,374.00 |
| Jun 30, 2025 | 31,002.00 |
| Dec 31, 2024 | 79,472.00 |
| Jun 30, 2024 | 45,840.00 |
| Dec 31, 2023 | 155,198.00 |
| Jun 30, 2023 | 680,562.00 |
| Dec 31, 2022 | 377,289.00 |
| Dec 31, 2021 | 193,217.00 |